Clinical Trials Browser

INDUSTRY × anetumab ravtansine × Tumor-Agnostic × Clear all

NCT02696642 2021-07-09

Phase I Study of Anetumab Ravtansine in Hepatic or Renal Impairment

Phase 1 Completed

Neoplasms